Document is current
Any future updates will be listed below
-
Authors
Takeshita, Kotaro
Hijioka, Susumu
Ikezawa, Kenji
Ogura, Takeshi
Kuwatani, Masaki
Fujimori, Nao
Doi, Shinpei
Endo, Masato
Matsubara, Saburo
Yamada, Reiko
Mashima, Hirosato
Kataoka, Mikinori
Takada, Ryoji
Okuda, Atsushi
Ohno, Akihisa
Katsukura, Nobuhiro
Suzuki, Hirosumi
Tanaka, Takamitsu
Sekine, Masanari
Kitamura, Hidetoshi
Okusaka, Takuji
-
Funding
Funding for this research was provided by:
The National Cancer Center Research and Development Fund (2022-A-16)
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 28 January 2025
First Online: 19 February 2025
Declarations
:
: Kotaro Takeshita, Susumu Hijioka, Kenji Ikezawa, Takeshi Ogura, Masaki Kuwatani, Nao Fujimori, Shinpei Doi, Masato Endo, Saburo Matsubara, Reiko Yamada, Hirosato Mashima, Mikinori Kataoka, Ryoji Takada, Atsushi Okuda, Akihisa Ohno, Nobuhiro Katsukura, Hirokiyo Suzuki, Takamitsu Tanaka, Masanari Sekine, Hidetoshi Kitamura, and Takuji Okusaka have no conflicts of interest to disclose.
: The protocol was developed before the initiation of the trial and was approved by the National Cancer Center Institutional Review Board (2021-224).
: Written informed consent was obtained from all participants before their inclusion in the study.
: Not applicable.
